The Ministry of Industry and Trade failed to win a 17.6 million ruble lawsuit against Tsito.

In the lawsuit, the agency stated that, according to the contract, the completion of the reconstruction of the Center for Innovative Technologies in Orthopedics was scheduled for 2021, but the permit for commissioning the facility was only issued in September 2022. The delay in commissioning the facility was the reason for the lawsuit.

The arbitration court, after reviewing the case materials, found that the subsidies were provided for by the federal target program "Development of the Pharmaceutical and Medical Industry of the Russian Federation for the Period up to 2020 and Beyond," but that the program was terminated by a decision of the Russian Government in December 2017. Therefore, at the time the claim was filed, the program, the violation of which served as the basis for the fine imposed on JSC CITO, did not exist. This served as the basis for the denial of the Ministry of Industry and Trade's claims in March 2025.

Within a month, the ministry filed an appeal, which the court also dismissed in May 2025.

Disagreeing with the decision, the agency filed a cassation appeal with the arbitration court in July, citing violations of substantive and procedural law, as well as inconsistencies between the findings and the circumstances and evidence. However, in September 2025, the court found no grounds to amend or overturn the decision.

Shortly before this, the Moscow Arbitration Court dismissed the Ministry of Industry and Trade's claim against JSC Biocad for a fine of 21.07 million rubles. The agency cited Sintez's failure to meet its revenue targets. However, the court ruled the agency's claim unfounded and should not be upheld.